"IMO and my opinion only, if the CEO announced his voluntary retirement thus handing over operations and decision making to someone else, the pps would soar. The Market knows exactly what we have and have shown their vote of no confidence through the pps . In any potentials being realized under current Management. IMO and my option only the pending FDA approval will fall flat without change in operations. JMHO Have a great weekend. GLTA The Market will only act favorably to a change in operations from outside the family. AW would become an instant Hero."
I concur, the magical aura of the ActiPatch device would be allowed to flourish in areas of sales, profits and share price. Never a question about the efficacy of ActiPatch or the needs of 100's of millions suffering from acute and chronic pain with no alternative but drugs and side-effects. ActiPatch is a wonderful solution.
The market knows exactly what is going on at BIEL and the price is a simple reflection of that. If, as you suggest, the solution is to have the company managed by other than family members, which I agree is the only solution, then, indeed, the Whelan legacy will be that of a start-up hero who knew exactly when to allow his company and shareholders to thrive. He is also aware that only fools don't change their minds.
If those who are for an immediate change in management are wrong and things should remain as is, then the only indicator that the status quo is the correct path will be an immediate positive change in share price. As an observer, I look forward with interest for whatever change is best for shareholders, the status quo (currently in the toilet) or change, always remembering that the Whelan family controls about 25 billion shares and the rest of shareholders, less.
